Kiss István
Szent Imre Oktató Kórház Nephrologia-Hypertonia Profil Budapest.
Orv Hetil. 2013 May 12;154(19):753-6. doi: 10.1556/OH.2013.29609.
The author analyzes the applicability of the renin-angiotensin system blocking drugs in patients with chronic kidney disease emphasizing their renoprotective (blood pressure and albuminuria lowering) and cardiovascular risk decreasing effects. As opposed to a previously-published statement, the author believes that their application is fundamental, particularly in combination with calcium-antagonist drugs. Relying on many references the author suggests that combined treatment with different renin-angiotensin system blocking drugs cannot be entirely ruled out, although it is not yet recommended.
作者分析了肾素-血管紧张素系统阻断药物在慢性肾病患者中的适用性，强调了它们的肾脏保护作用（降低血压和蛋白尿）以及降低心血管风险的作用。与之前发表的观点相反，作者认为这些药物的应用至关重要，尤其是与钙拮抗剂联合使用时。基于众多参考文献，作者表明，尽管目前尚不推荐，但不能完全排除不同肾素-血管紧张素系统阻断药物联合治疗的可能性。
